Tak Paul Peter
SEC insider (Form 3/4/5 filer). CIK 0001873905. Chief Executive Officer at Candel Therapeutics, Inc. (CADL). 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in NEEDHAM, MA.
Companies Tak Paul Peter has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Director, Officer, Chief Executive Officer
Tak Paul Peter
CIK: 0001873905
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Candel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 11, 2026CADL
Candel Therapeutics, Inc.
SaleDirect59.4K shares at avg. $10.46$621K - Sep 10, 2026CADL
Candel Therapeutics, Inc.
ExerciseDirect125K shares at avg. $1.55$194K - Sep 10, 2026CADL
Candel Therapeutics, Inc.
SaleDirect220.9K shares at avg. $11.50$2.5M - Jan 26, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
629K shares- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardDirect42.8K shares at avg. $4.67$200K - Mar 19, 2025CADL
Candel Therapeutics, Inc.
SaleDirect400 shares at avg. $9.00$4K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
SaleDirect25.8K shares at avg. $8.77$226K - Feb 12, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
525K shares- - Jan 15, 2025CADL
Candel Therapeutics, Inc.
SaleDirect21.7K shares at avg. $7.22$157K - Jan 8, 2025CADL
Candel Therapeutics, Inc.
SaleDirect21.2K shares at avg. $8.22$174K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 | CADL Candel Therapeutics, Inc. | Sale | 59,379 | $10.46 | $620,891 | Direct |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | Exercise | 125,000 | $1.55 | $193,750 | Direct |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | Sale | 220,866 | $11.50 | $2,539,893 | Direct |
| Jan 26, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 629,000 | - | - | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award | 42,826 | $4.67 | $199,997 | Direct |
| Mar 19, 2025 | CADL Candel Therapeutics, Inc. | Sale | 400 | $9.00 | $3,601 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Sale | 25,772 | $8.77 | $226,023 | Direct |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 525,000 | - | - | Direct |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Sale | 21,704 | $7.22 | $156,811 | Direct |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Sale | 21,172 | $8.22 | $173,996 | Direct |
1-10 of 12 transactions